Ascendis Pharma A/S (ASND)
225.60
-5.10
(-2.21%)
USD |
NASDAQ |
Sep 25, 16:00
225.82
+0.22
(+0.10%)
After-Hours: 19:59
Ascendis Pharma Net Income (TTM) : 866.59M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 866.59M |
| March 31, 2026 | 581.90M |
| December 31, 2025 | -253.97M |
| September 30, 2025 | -255.94M |
| June 30, 2025 | -293.64M |
| March 31, 2025 | -367.35M |
| December 31, 2024 | -409.98M |
| September 30, 2024 | -462.37M |
| June 30, 2024 | -529.87M |
| March 31, 2024 | -544.28M |
| December 31, 2023 | -521.07M |
| September 30, 2023 | -639.21M |
| June 30, 2023 | -632.83M |
| March 31, 2023 | -587.22M |
| December 31, 2022 | -609.00M |
| September 30, 2022 | -518.65M |
| June 30, 2022 | -443.27M |
| March 31, 2022 | -518.73M |
| December 31, 2021 | -453.58M |
| September 30, 2021 | -498.02M |
| June 30, 2021 | -545.60M |
| March 31, 2021 | -488.14M |
| December 31, 2020 | -482.26M |
| September 30, 2020 | -405.56M |
| June 30, 2020 | -291.19M |
| Date | Value |
|---|---|
| March 31, 2020 | -252.84M |
| December 31, 2019 | -243.98M |
| September 30, 2019 | -191.50M |
| June 30, 2019 | -203.09M |
| March 31, 2019 | -164.02M |
| December 31, 2018 | -153.97M |
| September 30, 2018 | -157.72M |
| June 30, 2018 | -158.01M |
| March 31, 2018 | -164.70M |
| December 31, 2017 | -140.64M |
| September 30, 2017 | -118.13M |
| June 30, 2017 | -98.71M |
| March 31, 2017 | -79.89M |
| December 31, 2016 | -75.72M |
| September 30, 2016 | -71.12M |
| June 30, 2016 | -58.88M |
| March 31, 2016 | -60.51M |
| December 31, 2015 | -37.89M |
| September 30, 2015 | -31.06M |
| June 30, 2015 | -25.55M |
| March 31, 2015 | -11.85M |
| December 31, 2014 | -12.54M |
| September 30, 2014 | -3.174M |
| June 30, 2014 | 0.3969M |
| March 31, 2014 | 3.329M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Novo Nordisk A/S | 18.19B |
| Evaxion AS | -8.683M |
| Genmab A/S | 785.93M |
| Zealand Pharma A/S | 425.33M |